Goodwin Law - Big Molecule Watch (@goodwinlaw.bsky.social)

FDA Updates Guidance on Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment & other Quality-Related Considerations #FDA #Biosimilars #BigMoleculeWatch www.bigmoleculewatch.com/2025/09/18/f...

loading . . .

FDA Updates Guidance on Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment & other Quality-Related Considerations This month, FDA issued its new final guidance to replace a draft guidance that issued on May 22, 2019 titled “Development of Therapeutic Protein Biosimilars: Comparative Analytical Assessment and Othe... https://www.bigmoleculewatch.com/2025/09/18/fda-updates-guidance-on-development-of-therapeutic-protein-biosimilars-comparative-analytical-assessment-other-quality-related-considerations/